These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3024202)

  • 1. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
    Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).
    Rasey JS; Krohn KA; Grunbaum Z; Spence AM; Menard TW; Wade RA
    Radiat Res; 1986 Jun; 106(3):366-79. PubMed ID: 3012625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913).
    Rasey JS; Grunbaum Z; Krohn KA; Menard TW; Spence AM
    Radiat Res; 1985 Apr; 102(1):130-7. PubMed ID: 2984715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors.
    Rasey JS; Krohn KA; Menard TW; Spence AM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1487-90. PubMed ID: 3019965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
    Murray D; Altschuler EM; Hunter N; Milas L
    Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
    Wasserman TH; Phillips TL; Ross G; Kane LJ
    Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].
    Ebe K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Feb; 47(2):307-17. PubMed ID: 3039456
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.
    Utley JF; Marlowe C; Waddell WJ
    Radiat Res; 1976 Nov; 68(2):284-91. PubMed ID: 185642
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for initial clinical trials and future development of radioprotectors.
    Phillips TL
    Cancer Clin Trials; 1980; 3(2):165-73. PubMed ID: 6253097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
    Livesey JC; Rasey JS; Vertrees S; Freeman LM; Magee S; Nelson NJ; Chin L; Grunbaum Z; Krohn KA
    Pharmacol Ther; 1988; 39(1-3):215-7. PubMed ID: 2849127
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
    Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
    Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
    Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.
    Hanson WR
    Radiat Res; 1987 Aug; 111(2):361-73. PubMed ID: 2819937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913.
    Rasey JS; Magee S; Nelson N; Chin L; Krohn KA
    Radiother Oncol; 1990 Feb; 17(2):167-73. PubMed ID: 2157242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721.
    Penhaligon M
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1541-4. PubMed ID: 6090358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327.
    Sigdestad CP; Grdina DJ; Connor AM; Hanson WR
    Radiat Res; 1986 May; 106(2):224-33. PubMed ID: 3010368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D; Bensely D; Schein P
    Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of normal tissue damage induced by photodynamic therapy.
    Sigdestad CP; Fingar VH; Wieman TJ; Lindberg RD
    Br J Cancer Suppl; 1996 Jul; 27():S89-92. PubMed ID: 8763855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.